GAL and neoplasm: Our preclinical data in tumor bearing mice (see below), imply that the injection of α-gal glycolipids into melanoma lesions results in expression of α-gal epitopes on the melanoma cells within the treated lesion, in a manner similar to the expression of these epitopes on pig cells.